Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, Epac1, as a key driver of idiopathic pulmonary fibrosis (IPF), a chronic ...

Columnist Sam Kirton had to make some adjustments after his IPF diagnosis, but there are still plenty of ways to find joy, he says.

Patients with connective tissue disease-related interstitial lung disease show slower decline in lung function and longer ...

A phase 3 clinical trial reports that nerandomilast was associated with a smaller decline in forced vital capacity in patients with progressive pulmonary fibrosis over 52 weeks.

SAN FRANCISCO — Two doses of 52-week nerandomilast, a phosphodiesterase 4B inhibitor, lowered FVC decline vs. placebo in patients with progressive pulmonary fibrosis, according to results ...

In a phase 2 trial involving patients with idiopathic pulmonary fibrosis, treatment with nerandomilast stabilized lung function over a period of 12 weeks.

With extensive expertise in pulmonary and respiratory diseases, Novotech offers biotech and pharmaceutical partners an accelerated path to market. The company’s comprehensive capabilities include ...

Idiopathic pulmonary fibrosis (IPF) is the most prevalent type of progressive interstitial lung disease, characterised by irreversible fibrosis and a poor long-term prognosis. Dr Ahmed Fahim discusses ...

Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) ...

A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary Fibrosis Registry.

interstitial lung disease pulmonary fibrosis molecular imaging Interstitial lung diseases (ILDs) are a diverse group of pulmonary pathologies represented by varying degrees of inflammation or fibrosis ...